111 related articles for article (PubMed ID: 21292369)
1. Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
Collette DC; Zechel MA
J Oral Maxillofac Surg; 2011 Sep; 69(9):2383-6. PubMed ID: 21292369
[TBL] [Abstract][Full Text] [Related]
2. Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients.
Husak R; Zouboulis CC; Sander-Bähr C; Hummel M; Orfanos CE
Br J Dermatol; 2005 Mar; 152(3):590-1. PubMed ID: 15787847
[No Abstract] [Full Text] [Related]
3. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
Calista D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
[TBL] [Abstract][Full Text] [Related]
4. The management of oral human papillomavirus with topical cidofovir: a case report.
DeRossi SS; Laudenbach J
Cutis; 2004 Mar; 73(3):191-3. PubMed ID: 15074348
[TBL] [Abstract][Full Text] [Related]
5. 1% topical cidofovir used as last alternative to treat viral infections.
Briand S; Milpied B; Navas D; Thomare P; Stalder JF
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429
[No Abstract] [Full Text] [Related]
6. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
7. Treatment of anal intraepithelial neoplasia: has it come of age?
Nathan M
AIDS; 2013 Feb; 27(4):651-2. PubMed ID: 23364443
[No Abstract] [Full Text] [Related]
8. Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
Kottke MD; Parker SR
J Am Acad Dermatol; 2006 Sep; 55(3):533-6. PubMed ID: 16908370
[TBL] [Abstract][Full Text] [Related]
9. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
[No Abstract] [Full Text] [Related]
10. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir.
Meadows KP; Tyring SK; Pavia AT; Rallis TM
Arch Dermatol; 1997 Aug; 133(8):987-90. PubMed ID: 9267245
[TBL] [Abstract][Full Text] [Related]
11. Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
De Socio GV; Simonetti S; Rosignoli D; Minga P; Tomassini GM; Baldelli F
Int J STD AIDS; 2008 Oct; 19(10):715-6. PubMed ID: 18824628
[TBL] [Abstract][Full Text] [Related]
12. [Resolution of recalcitrant condyloma acuminata in a patient with human immunodeficiency virus treated with cidofovir].
Tejera-Vaquerizo A; Bosch-García RJ; Fernández-Orland A; Herrera-Ceballos E
Actas Dermosifiliogr; 2008 Mar; 99(2):162-3. PubMed ID: 18346446
[No Abstract] [Full Text] [Related]
13. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
[TBL] [Abstract][Full Text] [Related]
14. Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
Di Lucca-Christment J; Jacobelli S; Gressier L; Plantier F; Laude H; Rozenberg F; Morini JP; Dallot A; Avril MF; Dupin N
AIDS; 2012 Feb; 26(4):523-6. PubMed ID: 22210631
[TBL] [Abstract][Full Text] [Related]
15. Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir.
Astriti M; Zeller V; Boutolleau D; Gautheret-Dejean A; Allen G; Seilhean D; Agut H; Bricaire F; Katlama C; Bossi P
J Infect; 2006 Apr; 52(4):237-42. PubMed ID: 16188320
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
Toutous-Trellu L; Hirschel B; Piguet V; Schiffer V; Saurat JH; Pechère M
Ann Dermatol Venereol; 2004 May; 131(5):445-9. PubMed ID: 15235531
[TBL] [Abstract][Full Text] [Related]
17. [Cidofovir gel 1% for treating papillomavirus lesions in a patient with congenital immunodeficiency].
Muñoz RM; Prado E; Cisneros JM; Bautista FJ
Enferm Infecc Microbiol Clin; 2010 Mar; 28(3):209-10. PubMed ID: 19733939
[No Abstract] [Full Text] [Related]
18. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
De Luca A; Ammassari A; Pezzotti P; Cinque P; Gasnault J; Berenguer J; Di Giambenedetto S; Cingolani A; Taoufik Y; Miralles P; Marra CM; Antinori A;
AIDS; 2008 Sep; 22(14):1759-67. PubMed ID: 18753934
[TBL] [Abstract][Full Text] [Related]
19. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Calista D
J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):484-8. PubMed ID: 11444271
[TBL] [Abstract][Full Text] [Related]
20. Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group.
Berenguer J; Mallolas J
Clin Infect Dis; 2000 Jan; 30(1):182-4. PubMed ID: 10619750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
